These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2327940)

  • 1. Permanent conversion of NIH3T3 cells transformed by activated c-Ha-ras, c-Ki-ras, N-ras, or c-raf, and of human pancreatic adenocarcinoma containing activated c-Ki-ras to apparently normal cells by treatment with the antibiotic azatyrosine.
    Shindo-Okada N; Makabe O; Nagahara H; Nishimura S
    Basic Life Sci; 1990; 52():309-12. PubMed ID: 2327940
    [No Abstract]   [Full Text] [Related]  

  • 2. Permanent conversion of mouse and human cells transformed by activated ras or raf genes to apparently normal cells by treatment with the antibiotic azatyrosine.
    Shindo-Okada N; Makabe O; Nagahara H; Nishimura S
    Mol Carcinog; 1989; 2(3):159-67. PubMed ID: 2675904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversion of human prostate tumorigenic growth by azatyrosine.
    Benoit RM; Eiseman J; Jacobs SC; Kyprianou N
    Urology; 1995 Sep; 46(3):370-7. PubMed ID: 7660512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-transformed, but not ras/myc-transformed, serum-free mouse embryo cells recover from growth suppression by azatyrosine.
    Nomura T; Ryoyama K; Okada G; Matano S; Nakamura S; Kameyama T
    Jpn J Cancer Res; 1992 Aug; 83(8):851-8. PubMed ID: 1383180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antibiotic, L-beta-(5-hydroxy-2-pyridyl)-alanine specifically inhibits growth of the NIH3T3 cells transformed by activated human c-Ha-ras and induces formation of flat revertant cells.
    Shindo-Okada N; Nagahara H; Yamaizumi Z; Makabe O; Nishimura S
    Nucleic Acids Symp Ser; 1988; (19):129-30. PubMed ID: 3067212
    [No Abstract]   [Full Text] [Related]  

  • 6. Azatyrosine. Mechanism of action for conversion of transformed phenotype to normal.
    Monden Y; Hamano Takaku F; Shindo Okada N; Nishimura S
    Ann N Y Acad Sci; 1999; 886():109-21. PubMed ID: 10667209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azatyrosine inhibits neurite outgrowth of PC12 cells induced by oncogenic Ras.
    Fujita-Yoshigaki J; Yokoyama S; Shindo-Okada N; Nishimura S
    Oncogene; 1992 Oct; 7(10):2019-24. PubMed ID: 1328988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of action of azatyrosine: recent process].
    Monden Y; Shindo-Okada N; Nishimura S
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1563-70. PubMed ID: 9309155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of c-Ki-ras gene in human pancreatic cancer.
    Prassolov VS; Sakamoto H; Nishimura S; Terada M; Sugimura T
    Jpn J Cancer Res; 1985 Sep; 76(9):792-5. PubMed ID: 3932275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of revertant cells induced from transformed cells by the treatment with an antibiotic, azatyrosine].
    Okada N; Nishimura S
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):500-1. PubMed ID: 2181938
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation of azatyrosine-induced revertants from ras-transformed human mammary epithelial cells.
    Kyprianou N; Taylor-Papadimitriou J
    Oncogene; 1992 Jan; 7(1):57-63. PubMed ID: 1741165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reversal of malignant cell phenotype of human pancreatic adenocarcinoma cell line by recombinant retroviral vector expressing antisense Ki-ras].
    Li H; Wang Z; Liu T
    Zhonghua Bing Li Xue Za Zhi; 1995 Oct; 24(5):288-91. PubMed ID: 8745475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
    Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
    Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine.
    Krzyzosiak WJ; Shindo-Okada N; Teshima H; Nakajima K; Nishimura S
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4879-83. PubMed ID: 1594588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation.
    Yamada H; Yoshida T; Sakamoto H; Terada M; Sugimura T
    Biochem Biophys Res Commun; 1986 Oct; 140(1):167-73. PubMed ID: 3778442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity pattern of normal and Ha-ras transformed NIH3T3 fibroblasts to antineoplastic drugs.
    Toffoli G; Viel A; Tumiotto L; Buttazzi P; Biscontin G; Boiocchi M
    Tumori; 1989 Oct; 75(5):423-8. PubMed ID: 2690431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity to the parvovirus minute virus of mice as a probe for azatyrosine-mediated phenotypic reversion of spontaneously transformed cells.
    Koering CE; Vennin-Fikry M; Dupressoir T; Schlehofer JR; Rommelaere J; Stehelin D
    J Gen Virol; 1996 May; 77 ( Pt 5)():913-7. PubMed ID: 8609487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The inhibitory effect of antisense oligodeoxynucleotides on the growth of human pancreatic adenocarcinoma cell lines].
    Liu TH
    Zhonghua Bing Li Xue Za Zhi; 1993 Feb; 22(1):25-9. PubMed ID: 8330327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.
    Fralix KD; Ahmed MM; Mattingly C; Swiderski C; McGrath PC; Venkatasubbarao K; Kamada N; Mohiuddin M; Strodel WE; Freeman JW
    Cancer; 2000 May; 88(9):2010-21. PubMed ID: 10813711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo.
    Shi XH; Liang ZY; Ren XY; Liu TH
    Cancer Gene Ther; 2009 Mar; 16(3):227-36. PubMed ID: 18949011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.